A Multicenter, Randomized, Parallel, Double Blind, Placebo-controlled Phase III Study to Evaluate Safety and Efficacy of Ilaprazole 20mg in Patients With Non-erosive Reflux Disease(NERD)
Not yet recruiting
Phase of Trial: Phase III
Latest Information Update: 20 Aug 2018
At a glance
- Drugs Ilaprazole (Primary)
- Indications Gastro-oesophageal reflux
- Focus Therapeutic Use
- Sponsors Il-Yang
- 07 Aug 2018 Planned End Date changed from 1 Aug 2019 to 1 Dec 2019.
- 07 Aug 2018 Planned primary completion date changed from 1 Mar 2019 to 1 Jul 2019.
- 07 Aug 2018 Planned initiation date changed from 1 Apr 2018 to 1 Aug 2018.